CLINICAL_TRIALS
trial_result
· 2016-01-01
Clinical Trial Update: Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes [Phase 1]
Summary
Phase 1 clinical trial update assessing the efficacy of albuterol for treating congenital myasthenic syndromes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Congenital Myasthenic Syndrome | Phase 1 | Status: COMPLETED